ENVESTNET ASSET MANAGEMENT INC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 331 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,320,560
+167.0%
35,642
+152.3%
0.00%
+100.0%
Q2 2023$1,617,973
+6.5%
14,128
+28.2%
0.00%0.0%
Q1 2023$1,518,928
+57.4%
11,020
+48.0%
0.00%
Q4 2022$964,892
+40.7%
7,446
+20.0%
0.00%
Q3 2022$686,000
+198.3%
6,206
+102.7%
0.00%
Q2 2022$230,000
-3.8%
3,062
-0.1%
0.00%
Q1 2022$239,000
-21.9%
3,064
-9.7%
0.00%
Q4 2021$306,000
-24.8%
3,393
-22.8%
0.00%
Q3 2021$407,000
+48.5%
4,397
+24.8%
0.00%
Q2 2021$274,000
-29.6%
3,523
-32.5%
0.00%
Q1 2021$389,000
-75.5%
5,217
-43.9%
0.00%
-100.0%
Q4 2020$1,586,000
+22.9%
9,300
+1.3%
0.00%0.0%
Q3 2020$1,290,000
+131.2%
9,185
+164.2%
0.00%0.0%
Q2 2020$558,000
+63.2%
3,477
-0.5%
0.00%
Q1 2020$342,000
-19.7%
3,495
+5.9%
0.00%
Q4 2019$426,000
+40.6%
3,299
-18.0%
0.00%
Q3 2019$303,000
-33.3%
4,024
+34.6%
0.00%
-100.0%
Q2 2019$454,000
+5.3%
2,990
-17.3%
0.00%0.0%
Q1 2019$431,000
+28.3%
3,616
+17.4%
0.00%0.0%
Q4 2018$336,000
+148.9%
3,081
+201.8%
0.00%
Q2 2018$135,000
+80.0%
1,021
+1.3%
0.00%
Q1 2018$75,000
+23.0%
1,008
-7.5%
0.00%
Q4 2017$61,000
+29.8%
1,090
+5.8%
0.00%
Q3 2017$47,000
+135.0%
1,030
+80.4%
0.00%
Q2 2017$20,000
+53.8%
571
+38.3%
0.00%
Q1 2017$13,000
-18.8%
413
-28.2%
0.00%
Q4 2016$16,0005750.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 112,689$14,541,00014.93%
Casdin Capital, LLC 670,000$86,457,0007.95%
Logos Global Management LP 226,002$29,163,0007.19%
Avoro Capital Advisors LLC 1,760,000$227,110,0006.67%
Camber Capital Management LP 600,000$77,424,0003.94%
STANSBERRY ASSET MANAGEMENT, LLC 71,133$9,179,0003.74%
Eventide Asset Management 996,000$128,524,0003.62%
CADIAN CAPITAL MANAGEMENT, LP 550,000$70,972,0003.14%
RTW INVESTMENTS, LP 605,762$78,168,0002.95%
Consonance Capital Management LP 356,145$45,957,0002.80%
View complete list of SAREPTA THERAPEUTICS INC shareholders